Labocof 4mg/4mg/50mg/5mg/450mg Tablet
By Labocof
Rx
10 Tablet in a Strip

Composition
Bromhexine(4mg) + Chlorpheniramine Maleate(4mg) + Guaifenesin(50mg) + Phenylephrine(5mg) + Paracetamol(450mg)

Manufacturer - Laborate Pharmaceuticals India Ltd
E-11, Industrial Area, Panipat, Haryana-132103

Expires on or after
January, 2028

liver
Labocof 4mg/4mg/50mg/5mg/450mg Tablet needs to be used carefully in individuals with liver problems. It may require adjustments in the dosage of the medication. Therefore, it is crucial to seek advice from your doctor before taking Labocof 4mg/4mg/50mg/5mg/450mg Tablet if you have any liver issues. It is important to note that this medicine is not suitable for individuals with severe or active liver disease. Always prioritize consulting with your healthcare provider for the appropriate guidance regarding the usage of Labocof 4mg/4mg/50mg/5mg/450mg Tablet.

kidney
Labocof 4mg/4mg/50mg/5mg/450mg Tablet seems safe for kidney patients without needing dose adjustment. However, it may lead to increased drowsiness for those with end-stage kidney disease. Consulting your doctor is recommended.

alcohol
It is not safe to drink alcohol while taking Labocof 4mg/4mg/50mg/5mg/450mg Tablet.

driving
Labocof 4mg/4mg/50mg/5mg/450mg Tablet can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Labocof 4mg/4mg/50mg/5mg/450mg Tablet may not be safe during pregnancy as studies in animals have shown potential harm to the baby. Consult your doctor for a thorough evaluation of the benefits and risks before using this medication.

breastfeeding
Labocof 4mg/4mg/50mg/5mg/450mg Tablet may not be safe during breastfeeding as it could pass into breastmilk and harm the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | RESPIRATORY |
| Action Class | - |
₹22
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
